PO.TB02.02 · 肿瘤生物学
工程化多重光学传感器用于检测肿瘤微环境中的炎症细胞因子
Engineered multiplexed optical sensors to detect inflammatory cytokines in the tumor microenvironment
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
炎症既是癌症发生的一个标志,也是癌症进展的结果。慢性炎症通路促进实体瘤生长、转移和免疫逃逸。事实上,导致肿瘤形成的几种炎症细胞因子的慢性信号传导包括TNF-alpha,而持续的IL-6信号传导驱动细胞存活和增殖以及血管生成。然而,IL-12是一种强效抗肿瘤细胞因子,除抑制血管生成外,还促进巨噬细胞和T细胞的细胞毒性。尽管这些细胞因子很重要,但在癌症发生和进展过程中,对肿瘤微环境中实时炎症细胞因子信号进行建模和监测却很困难。在动物肿瘤模型中非侵入性地实现这一点,将有助于更好地理解这一重要癌症标志的关键驱动因素,而在患者中实现这一点则可作为诊断和预后工具。
为此,我们工程化了一个针对炎症细胞因子TNF-alpha、IL-6和IL-12的多重光学传感器平台。各传感器由物种分选的单壁碳纳米管(SWCNT)合成,其表现出组织透明的近红外荧光。对于每种细胞因子,我们将抗体或ssDNA适配体非共价连接到SWCNT上,从而实现分子特异性检测,并在生物标志物结合时改变发射光谱。我们发现,在使用钝化剂聚合物和蛋白质抑制非特异性表面吸附后,传感器性能可定量,检测限处于临床范围内。此外,我们证明了能够在溶液中同时检测IL-6和IL-12这两种分别为关键促肿瘤和抗肿瘤的细胞因子,以及巨噬细胞响应促炎刺激而分泌的IL-6。总之,我们预期这些炎症细胞因子监测传感器将进一步在体内部署,并转化应用于患者诊断和预后分析。
查看英文原文 English abstract
Inflammation is a hallmark of cancer development as well as a consequence of cancer progression. Chronic inflammatory pathways promote solid tumor growth, metastasis, and immune evasion. Indeed, chronic signaling of several inflammatory cytokines that lead to tumor formation include TNF-alpha, while persistent IL-6 signaling drives cell survival and proliferation as well as angiogenesis. IL-12, however, is a powerful anti-tumor cytokine, which promotes macrophage and T-cell cytotoxicity in addition to inhibiting angiogenesis. Despite their importance, it is difficult to model and monitor real-time inflammatory cytokine signaling in the tumor microenvironment during cancer initiation and progression. The ability to do so non-invasively in animal tumor models would allow for a better understanding of the key drivers of this important cancer hallmark, while the ability to do so in a patient could be a diagnostic and prognostic tool.
To this end, we have engineered a multiplexed optical sensor platform for inflammatory cytokines TNF-alpha, IL-6, and IL-12. Individual sensors are synthesized from species-sorted single-walled carbon nanotubes (SWCNT), which exhibit tissue-transparent near-infrared fluorescence. For each cytokine, we non-covalently attached an antibody or ssDNA aptamer to SWCNT, allowing for molecularly-specific detection and a change in emission spectra upon biomarker binding. We found that sensor performance was quantitative with a limit of detection in the clinical range following inhibition of non-specific surface adsorption with passivation agent polymers and proteins. Further, we demonstrated the ability to detect IL-6 and IL-12, key pro-tumor and anti-tumor cytokines respectively, simultaneously in solution, as well as IL-6 excreted by macrophages in response to pro-inflammatory stimuli. Together, we anticipate further deployment of these inflammatory cytokine monitoring sensors in vivo and translation to patient diagnostic and prognostic profiling.
利益披露 Disclosure
R. M. Williams, None..
A. Ryan, None..
S. Rahman, None..
A. Israel, None.